[HTML][HTML] Assesment of polyphenolic compounds against biofilms produced by clinical Acinetobacter baumannii strains using in silico and in vitro models

L Mumtaz, A Farid, SY Alomar, N Ahmad… - Saudi Journal of …, 2023 - Elsevier
Several types of microbial infections are caused by Acinetobacter baumanii that has
developed resistance to antimicrobial agents. We therefore investigated the role of plant …

Multidrug-resistant Acinetobacter baumannii infections: looming threat in the Indian clinical setting

P Chandra, RV, S CS, U MK - Expert Review of Anti-infective …, 2022 - Taylor & Francis
Introduction The recent increase in multidrug-resistant strains of A. baumannii has increased
the incidences of ventilator-associated pneumoniae, catheter-associated urinary tract …

In vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075

X Wu, JD Chavez, DK Schweppe, C Zheng… - Nature …, 2016 - nature.com
The nosocomial pathogen Acinetobacter baumannii is a frequent cause of hospital-acquired
infections worldwide and is a challenge for treatment due to its evolved resistance to …

Prevalence of carbapenem-hydrolyzing OXA-type β-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection

SA Girija, JV Priyadharsini… - Acta Microbiologica et …, 2020 - akjournals.com
Acinetobacter baumannii produces carbapenemase-hydrolyzing class D β-lactamases
(CHDLs) as one of the major drug resistance mechanisms. This investigation is thus aimed …

Molecular Study of Acinetobacter baumannii Isolates for Metallo‐β‐Lactamases and Extended‐Spectrum‐β‐Lactamases Genes in Intensive Care Unit, Mansoura …

NM Alkasaby, M El Sayed Zaki - International journal of …, 2017 - Wiley Online Library
Acinetobacter baumannii (A. baumannii) has been known as a causative pathogen of
hospital acquired infections. The aim of this study is to examine the presence of A …

Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009)

DP Kateete, R Nakanjako, J Namugenyi, J Erume… - Springerplus, 2016 - Springer
Abstract Background Multidrug resistant Pseudomonas aeruginosa and Acinetobacter
baumannii are common causes of health care associated infections worldwide …

Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden …

W El-Kazzaz, L Metwally, R Yahia, N Al-Harbi… - Antibiotics, 2020 - mdpi.com
Acinetobacter spp. has gained fame from their ability to resist difficult conditions and their
constant development of antimicrobial resistance. This study aimed to investigate the …

Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India

S Vijayakumar, P Mathur, A Kapil, BK Das… - Indian Journal of …, 2019 - journals.lww.com
Methods: A total 75 non-repetitive clinical isolates of A. baumannii from five different centres
were included in this study. All the isolates were confirmed as A. baumannii by bla OXA-51 …

Prevalence of Carbapenemases in Carbapenem-Resistant Acinetobacter baumannii Isolates from the Kingdom of Bahrain

N Al-Rashed, KM Bindayna, M Shahid, NK Saeed… - Antibiotics, 2023 - mdpi.com
Background: Acinetobacter baumannii is regarded as a significant cause of death in
hospitals. The WHO recently added carbapenem-resistant Acinetobacter baumannii (CRAB) …

Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis

M Beig, E Parvizi, T Navidifar, N Bostanghadiri… - Plos one, 2024 - journals.plos.org
Background Carbapenem-resistant Acinetobacter baumannii (CRAB) is of critical concern in
healthcare settings, leading to limited treatment options. In this study, we conducted a …